A carregar...
Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26 years in the United States ☆
INTRODUCTION: In the United States, routine human papillomavirus (HPV) vaccination is recommended for females and males at age 11 or 12 years; the series can be started at age 9 years. Vaccination is also recommended for females through age 26 years and males through age 21 years. The objective of t...
Na minha lista:
| Publicado no: | Vaccine |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6745692/ https://ncbi.nlm.nih.gov/pubmed/29887325 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2018.04.071 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|